Corteva
CTVA
14.45
+0.54
+3.88%
Corteva
US · CTVA
#1654 by market cap
Listed 1970
14.45
+0.54
+3.88%
Live - 5344 symbols - heartbeat 288s ago
· 2026-10-08 07:00
Pre-market
14.53
+0.55%
After-hours
14.54
+0.62%
Overnight
14.44
-0.07%
- Market cap
- 9.64B
- P/E (TTM)i
- 9.44
- P/Bi
- 0.38
- EPSi
- 1.60
- Div yieldi
- 4.98%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on CTVA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.06, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.92% YoY
Margins
- Gross margin
- 47.29%
- Operating margin
- 15.05%
- Net margin
- 6.29%
Key ratios & quality
- Enterprise valuei
- 7.69B
- Altman Z-Scorei
- 1.06
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.29B | 13.85B | 14.22B | 15.66B | 17.46B | 17.23B | 16.91B | 17.40B |
| Gross profit | 4.34B | 5.27B | 5.71B | 6.44B | 7.02B | 7.31B | 7.38B | 8.23B |
| Selling & admin expenses | 3.04B | 3.07B | 3.04B | 3.21B | 3.17B | 3.18B | 3.20B | 3.49B |
| Research & development | 1.36B | 1.15B | 1.14B | 1.19B | 1.22B | 1.34B | 1.40B | 1.47B |
| Operating profit | -448.00M | 584.00M | 843.00M | 1.32B | 1.93B | 2.11B | 2.10B | 2.62B |
| Pretax profit | -6.81B | -316.00M | 675.00M | 2.35B | 1.43B | 1.09B | 1.28B | 1.69B |
| Tax | -31.00M | -46.00M | -81.00M | 524.00M | 210.00M | 152.00M | 412.00M | 484.00M |
| Net profit | -5.03B | -941.00M | 701.00M | 1.77B | 1.16B | 747.00M | 919.00M | 1.11B |
| Basic EPS | -7 | -1 | 1 | 2 | 2 | 1 | 1 | 2 |
| Diluted EPS | -6.76 | -1.28 | 0.91 | 2.37 | 1.58 | 1.03 | 1.30 | 1.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.42B | 6.46B | 2.62B | 3.91B | 4.91B | 6.38B |
| Gross profit | 2.08B | 3.52B | 974.00M | 1.66B | 2.53B | 3.66B |
| Selling & admin expenses | 751.00M | 1.16B | 731.00M | 842.00M | 877.00M | 1.16B |
| Research & development | 335.00M | 375.00M | 351.00M | 413.00M | 341.00M | 388.00M |
| Operating profit | 827.00M | 1.83B | -270.00M | 242.00M | 1.16B | 1.92B |
| Pretax profit | 784.00M | 1.80B | -370.00M | -530.00M | 858.00M | 1.63B |
| Tax | 117.00M | 422.00M | -62.00M | 7.00M | 133.00M | 408.00M |
| Net profit | 656.00M | 1.32B | -318.00M | -549.00M | 723.00M | 1.17B |
| Basic EPS | 1 | 2 | 0 | -1 | 1 | 2 |
| Diluted EPS | 0.95 | 1.92 | -0.47 | -0.82 | 1.07 | 1.73 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 22.97B | 13.52B | 14.77B | 15.55B | 16.80B | 16.26B | 15.10B | 17.34B |
| Cash & ST investments | 2.28B | 1.77B | 3.80B | 4.55B | 3.32B | 2.74B | 3.17B | 4.53B |
| Inventory | 5.31B | 5.03B | 4.88B | 5.18B | 6.81B | 6.90B | 5.43B | 5.67B |
| Total assets | 108.68B | 42.40B | 42.65B | 42.34B | 42.62B | 43.00B | 40.83B | 42.85B |
| Total current liabilities | 13.31B | 8.24B | 8.55B | 9.56B | 10.74B | 10.41B | 10.39B | 12.13B |
| Short-term debt | 2.15B | 7.00M | 3.00M | 17.00M | 24.00M | 198.00M | 750.00M | 894.00M |
| Long-term debt | 5.72B | 115.00M | 1.10B | 1.10B | 1.28B | 2.29B | 1.95B | 1.69B |
| Total liabilities | 33,530,000,000.00 | 17,842,000,000.00 | 17,586,000,000.00 | 16,721,000,000.00 | 17,077,000,000.00 | 17,717,000,000.00 | 16,795,000,000.00 | 18,459,000,000.00 |
| Total equity | 75.15B | 24.56B | 25.06B | 25.62B | 25.54B | 25.28B | 24.03B | 24.39B |
| Retained earnings | 0 | -425.00M | 0 | 524.00M | 250.00M | -41.00M | 55.00M | -67.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 16.59B | 16.00B | 16.44B | 17.34B | 17.39B | 16.36B |
| Cash & ST investments | 2.01B | 2.14B | 2.59B | 4.53B | 1.97B | 2.37B |
| Inventory | 5.13B | 4.32B | 5.31B | 5.67B | 5.20B | 4.44B |
| Total assets | 42.12B | 41.76B | 42.20B | 42.85B | 42.72B | 41.64B |
| Total current liabilities | 11.48B | 9.52B | 10.42B | 12.13B | 11.85B | 10.79B |
| Short-term debt | 2.29B | 1.94B | 2.69B | 894.00M | 1.67B | 3.19B |
| Long-term debt | 1.79B | 1.69B | 1.69B | 1.69B | 1.68B | 1.68B |
| Total liabilities | 17,596,000,000.00 | 15,608,000,000.00 | 16,737,000,000.00 | 18,459,000,000.00 | 18,112,000,000.00 | 16,239,000,000.00 |
| Total equity | 24.53B | 26.15B | 25.46B | 24.39B | 24.61B | 25.40B |
| Retained earnings | 587.00M | 1.53B | 834.00M | -67.00M | 436.00M | 1.22B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 483.00M | 1.07B | 2.06B | 2.73B | 872.00M | 1.77B | 2.15B | 3.41B |
| Depreciation & amortization | 2.79B | 1.60B | 1.18B | 1.24B | 1.22B | 1.21B | 1.23B | 1.20B |
| Free cash flow | -1.02B | -93.00M | 1.59B | 2.15B | 267.00M | 1.17B | 1.55B | 2.82B |
| Dividends paid | -2.81B | -511.00M | -388.00M | -397.00M | -418.00M | -439.00M | -458.00M | -475.00M |
| Stock buybacks / issuance | 0 | -25.00M | -275.00M | -950.00M | -1.00B | -756.00M | -1.01B | -1.07B |
| Ending cash balance | 5.02B | 2.17B | 3.87B | 4.84B | 3.62B | 3.16B | 3.42B | 4.73B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.11B | 947.00M | 193.00M | 4.38B | -2.89B | -466.00M |
| Depreciation & amortization | 296.00M | 301.00M | 300.00M | 306.00M | 297.00M | 339.00M |
| Free cash flow | -2.20B | 829.00M | 36.00M | 4.15B | -2.97B | -588.00M |
| Dividends paid | -116.00M | -772.00M | 534.00M | -121.00M | -121.00M | -620.00M |
| Stock buybacks / issuance | -270.00M | -- | -- | -301.00M | -250.00M | -- |
| Ending cash balance | 2.30B | 2.32B | 2.74B | 4.73B | 2.14B | 2.62B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -21.19 | -4.01 | 2.77 | 7.01 | 4.53 | 2.92 | 3.72 | 4.56 |
| ROA %i | -11.64 | -2.25 | 1.60 | 4.14 | 2.70 | 1.72 | 2.16 | 2.62 |
| ROIC %i | -19.26 | -3.57 | 2.67 | 6.57 | 4.17 | 2.56 | 3.61 | 4.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | 1.12 | 3.06 | 4.19 | 4.55 |
| EBIT margin %i | -31.34 | -1.30 | 5.06 | 15.18 | 8.62 | 7.70 | 8.92 | 10.74 |
| FCF / sales %i | -- | -- | 11.18 | 13.76 | 1.53 | 6.82 | 9.16 | 16.18 |
| Current ratioi | 1.73 | 1.64 | 1.73 | 1.63 | 1.56 | 1.56 | 1.45 | 1.43 |
| Quick ratioi | 0.57 | 0.89 | 1.02 | 0.98 | 0.84 | 0.79 | 0.85 | 0.90 |
| Debt / assetsi | 7.30 | 0.29 | 2.59 | 2.64 | 3.07 | 5.79 | 6.62 | 6.02 |
| LT debt / equityi | 7.75 | 0.47 | 4.44 | 4.33 | 5.07 | 9.15 | 8.21 | 6.98 |
| Interest coveragei | -58.92 | -1.32 | 16.00 | 79.20 | 19.05 | 5.69 | 6.47 | 10.38 |
| Revenue CAGR (3Y) %i | -- | -0.47 | -0.05 | 3.09 | 8.03 | 6.61 | 2.60 | -0.10 |
| Net income CAGR (3Y) %i | -- | -- | -35.47 | -- | -- | 2.58 | -19.81 | -1.56 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -9.60 | -10.43 | 119.28 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.65 | 5.48 | 6.43 | 4.56 | 4.78 | 3.95 |
| ROA %i | 2.66 | 3.37 | 3.82 | 2.62 | 2.74 | 2.42 |
| ROIC %i | 4.20 | 4.91 | 5.50 | 4.23 | 4.25 | 3.48 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.72 | 13.14 | 14.31 | 10.74 | 10.86 | 9.87 |
| FCF / sales %i | 12.49 | 15.10 | 15.19 | 16.18 | 11.44 | 3.53 |
| Current ratioi | 1.44 | 1.68 | 1.58 | 1.43 | 1.47 | 1.52 |
| Quick ratioi | 0.90 | 1.14 | 1.00 | 0.90 | 0.93 | 1.03 |
| Debt / assetsi | 9.69 | 8.69 | 10.36 | 6.02 | 7.86 | 11.71 |
| LT debt / equityi | 7.38 | 6.51 | 6.69 | 6.98 | 6.90 | 6.69 |
| Interest coveragei | 7.92 | 10.55 | 12.89 | 10.38 | 10.79 | 10.05 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Seed is the largest reported line at 71.05% of revenue, across 2 reported segments.
- The next-largest line, crop protection, is a distant second at 28.95% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Seed71.05%
crop protection28.95%
Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.